Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > EBITDA / Interest Expenses

Amneal Pharmaceuticals Inc EBITDA / Interest Expenses Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly EBITDA / Interest Expenses from 2016 to 2018. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Amneal Pharmaceuticals Inc EBITDA / Interest Expenses for the quarter ending December 12, 2018 was $3m a -59.70% decrease of -2m year over year
  • Amneal Pharmaceuticals Inc EBITDA / Interest Expenses for the last 12 months ending December 12, 2018 was $3m a -45.74% decrease of -1m year over year
  • Amneal Pharmaceuticals Inc Annual EBITDA / Interest Expenses for 2018 was $3m a -44.10% decrease of -1m from 2017
  • Amneal Pharmaceuticals Inc Annual EBITDA / Interest Expenses for 2017 was $4m a -32.28% decrease of -1m from 2016
  • Amneal Pharmaceuticals Inc Annual EBITDA / Interest Expenses for 2016 was $5m a -0.55% decrease of 0m from 2015
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
View Chart On Koyfin

Quarterly AMRX EBITDA / Interest Expenses Data

12/2018$3m
09/2018$3m
06/2018$3m
03/2018$4m
12/2017$4m
09/2017$4m
06/2017$3m
03/2017$4m
12/2016$8m

Annual AMRX EBITDA / Interest Expenses Data

2018$3m
2017$4m
2016$5m
2015$6m
2014$8m